|
OMIM |
Link |
Information gain |
01 |
|
undritz anomaly
|
[NCBI]
|
0.00316751
|
|
|
reticular dysgenesia
|
[NCBI]
|
0.00168723
|
|
|
MPO
|
[NCBI]
|
0.00139782
|
|
|
CHS
|
[NCBI]
|
0.00139661
|
|
|
LAD
|
[NCBI]
|
0.00126388
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
0.00123583
|
|
|
valinemia
|
[NCBI]
|
0.000905644
|
|
|
gangliosidosis, gm2, type iii, or juvenile type
|
[NCBI]
|
0.000789241
|
|
|
LGMD1D
|
[NCBI]
|
0.000789241
|
|
|
NCR
|
[NCBI]
|
0.000789241
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
0.000704385
|
|
|
FTNS
|
[NCBI]
|
0.000668694
|
|
|
methylmalonic aciduria and homocystinuria, cbld type
|
[NCBI]
|
0.000658288
|
|
|
MHA
|
[NCBI]
|
0.0006338
|
|
|
gonadal dysgenesis, xy type
|
[NCBI]
|
0.000614097
|
|
|
TSD
|
[NCBI]
|
0.000578679
|
|
|
CLN4B
|
[NCBI]
|
0.000577513
|
|
|
immune defect due to absence of thymus
|
[NCBI]
|
0.000577513
|
|
|
spondyloenchondrodysplasia
|
[NCBI]
|
0.000577513
|
|
|
CDAN3
|
[NCBI]
|
0.000546335
|
|
|
fabry disease
|
[NCBI]
|
0.000538167
|
|
|
SBS
|
[NCBI]
|
0.00052183
|
|
|
deafness, congenital, and onychodystrophy, recessive form
|
[NCBI]
|
0.0005192
|
|
|
carnitine deficiency, myopathic
|
[NCBI]
|
0.0005192
|
|
|
TAPVR1
|
[NCBI]
|
0.0005192
|
|
|
PHA
|
[NCBI]
|
0.00049529
|
|
|
myeloperoxidase deficiency
|
[NCBI]
|
0.000483108
|
|
|
TNF
|
[NCBI]
|
0.000480592
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.00045427
|
|
|
CTNS
|
[NCBI]
|
0.000443513
|
|
|
CDS
|
[NCBI]
|
0.00043855
|
|
|
scott syndrome
|
[NCBI]
|
0.000420242
|
|
|
gm1-gangliosidosis, type iii
|
[NCBI]
|
0.000403857
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
0.000393812
|
|
|
glycogen storage disease ii
|
[NCBI]
|
0.000375428
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
0.000367067
|
|
|
AD
|
[NCBI]
|
0.000366072
|
|
|
sandhoff disease
|
[NCBI]
|
0.00036575
|
|
|
hyperglycerolemia
|
[NCBI]
|
0.000337384
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
0.000337384
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
0.000333372
|
|
|
gaucher disease, type iii
|
[NCBI]
|
0.000315717
|
|
|
ITGB2
|
[NCBI]
|
0.000309699
|
|
|
niemann-pick disease, type b
|
[NCBI]
|
0.000307165
|
|
|
neuraminidase deficiency
|
[NCBI]
|
0.000295932
|
|
|
CGD
|
[NCBI]
|
0.000295365
|
|
|
mannosidosis, beta a, lysosomal
|
[NCBI]
|
0.000276237
|
|
|
CMM
|
[NCBI]
|
0.000274339
|
|
|
GPS
|
[NCBI]
|
0.000274339
|
|
|
hurler syndrome
|
[NCBI]
|
0.000272736
|
|
|
gm1-gangliosidosis, type ii
|
[NCBI]
|
0.00026568
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.000260555
|
|
|
maple syrup urine disease
|
[NCBI]
|
0.000256297
|
|
|
EGF
|
[NCBI]
|
0.000239367
|
|
|
cystinosis, adult nonnephropathic
|
[NCBI]
|
0.000233229
|
|
|
fructose-1,6-bisphosphatase deficiency
|
[NCBI]
|
0.000233229
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
0.00023175
|
|
|
CF
|
[NCBI]
|
0.000229198
|
|
|
MAFD6
|
[NCBI]
|
0.000224921
|
|
|
krabbe disease
|
[NCBI]
|
0.000211368
|
|
|
morquio syndrome b
|
[NCBI]
|
0.000207119
|
|
|
G6PD
|
[NCBI]
|
0.000182722
|
|
|
MAFD1
|
[NCBI]
|
0.000179095
|
|
|
HLA-A
|
[NCBI]
|
0.000172666
|
|
|
F3
|
[NCBI]
|
0.000170812
|
|
|
lazy leukocyte syndrome
|
[NCBI]
|
0.000166932
|
|
|
acyl-coa dehydrogenase, long-chain, deficiency of
|
[NCBI]
|
0.000166932
|
|
|
TH
|
[NCBI]
|
0.000164533
|
|
|
gaucher disease, type i
|
[NCBI]
|
0.000163514
|
|
|
NGFB
|
[NCBI]
|
0.000160226
|
|
|
glycogen storage disease iii
|
[NCBI]
|
0.000159033
|
|
|
glycogen storage disease vii
|
[NCBI]
|
0.000158616
|
|
|
mucolipidosis ii
|
[NCBI]
|
0.000154008
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
0.000153315
|
|
|
mucolipidosis iiia
|
[NCBI]
|
0.000143055
|
|
|
PTH
|
[NCBI]
|
0.000140047
|
|
|
phosphorylase kinase deficiency of liver and muscle, autosomal recessive
|
[NCBI]
|
0.00013804
|
|
|
IFNA1
|
[NCBI]
|
0.000136917
|
|
|
hyperprolinemia, type ii
|
[NCBI]
|
0.000127971
|
|
|
schindler disease, type i
|
[NCBI]
|
0.000127971
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
0.000126079
|
|
|
MG
|
[NCBI]
|
0.00012382
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
0.000122402
|
|
|
immunoerythromyeloid hypoplasia
|
[NCBI]
|
0.000122343
|
|
|
hemopoietic proliferation
|
[NCBI]
|
0.000122343
|
|
|
chondrodysplasia calcificans metaphysealis
|
[NCBI]
|
0.000122343
|
|
|
blood group--en
|
[NCBI]
|
0.000122343
|
|
|
phosphatase, acid, of tissues
|
[NCBI]
|
0.000122343
|
|
|
lymphoblastic transformation, inhibition of
|
[NCBI]
|
0.000122343
|
|
|
CDG2D
|
[NCBI]
|
0.000122343
|
|
|
RHE
|
[NCBI]
|
0.000122343
|
|
|
angiokeratoma corporis diffusum with arteriovenous fistulas
|
[NCBI]
|
0.000122343
|
|
|
SAPX
|
[NCBI]
|
0.000122343
|
|
|
insulin receptors, familial increase in
|
[NCBI]
|
0.000122343
|
|
|
myelolymphatic insufficiency
|
[NCBI]
|
0.000122343
|
|
|
GFAP
|
[NCBI]
|
0.000121164
|
|
|
glutathione synthetase deficiency of erythrocytes, hemolytic anemia due to
|
[NCBI]
|
0.000119544
|
|
|
mucolipidosis iv
|
[NCBI]
|
0.000115588
|
|
|
aryl hydrocarbon hydroxylase inducibility
|
[NCBI]
|
0.000112311
|
|
|
hexokinase deficiency hemolytic anemia
|
[NCBI]
|
0.000112311
|
|
|
ICAM3
|
[NCBI]
|
0.000107415
|
|
|
sea-blue histiocyte disease
|
[NCBI]
|
0.000105985
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
0.000103541
|
|
|
CCK
|
[NCBI]
|
0.000102298
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
0.000100372
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
0.000100372
|
|
|
epstein syndrome
|
[NCBI]
|
0.000100372
|
|
|
MSD
|
[NCBI]
|
9.85128e-05
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
9.83169e-05
|
|
|
ACHE
|
[NCBI]
|
9.61581e-05
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
9.59408e-05
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
[NCBI]
|
9.5334e-05
|
|
|
BDNF
|
[NCBI]
|
9.45519e-05
|
|
|
AVP
|
[NCBI]
|
9.34507e-05
|
|
|
SLPI
|
[NCBI]
|
9.23532e-05
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
9.15784e-05
|
|
|
MYH9
|
[NCBI]
|
9.15498e-05
|
|
|
HRH4
|
[NCBI]
|
9.12655e-05
|
|
|
CDG2C
|
[NCBI]
|
9.07703e-05
|
|
|
RP
|
[NCBI]
|
8.80893e-05
|
|
|
VRNI
|
[NCBI]
|
8.75214e-05
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
8.70894e-05
|
|
|
glutathione synthetase deficiency
|
[NCBI]
|
8.66042e-05
|
|
|
FA
|
[NCBI]
|
8.61831e-05
|
|
|
FTD
|
[NCBI]
|
8.61831e-05
|
|
|
CLN3
|
[NCBI]
|
8.50382e-05
|
|
|
PWS
|
[NCBI]
|
8.49154e-05
|
|
|
hyaluronidase deficiency
|
[NCBI]
|
8.34459e-05
|
|
|
sarcosinemia
|
[NCBI]
|
8.34459e-05
|
|
|
amish infantile epilepsy syndrome
|
[NCBI]
|
8.34459e-05
|
|
|
dermographism, familial
|
[NCBI]
|
8.34459e-05
|
|
|
leukocyte nuclear appendages, hereditary prevalence of
|
[NCBI]
|
8.34459e-05
|
|
|
IN
|
[NCBI]
|
8.34459e-05
|
|
|
GUK2
|
[NCBI]
|
8.34459e-05
|
|
|
NPY
|
[NCBI]
|
8.33509e-05
|
|
|
JAM2
|
[NCBI]
|
8.32804e-05
|
|
|
FUCA2
|
[NCBI]
|
8.32804e-05
|
|
|
HEXA
|
[NCBI]
|
8.32452e-05
|
|
|
alpha-methylacetoacetic aciduria
|
[NCBI]
|
8.27765e-05
|
|
|
EGFR
|
[NCBI]
|
8.14678e-05
|
|
|
HEXB
|
[NCBI]
|
8.05204e-05
|
|
|
VIP
|
[NCBI]
|
7.90572e-05
|
|
|
WAS
|
[NCBI]
|
7.8971e-05
|
|
|
MYO9B
|
[NCBI]
|
7.76136e-05
|
|
|
HPA-2
|
[NCBI]
|
7.76136e-05
|
|
|
GLUD1
|
[NCBI]
|
7.70831e-05
|
|
|
FMF
|
[NCBI]
|
7.4257e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
7.28971e-05
|
|
|
wolman disease
|
[NCBI]
|
6.96383e-05
|
|
|
ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis
|
[NCBI]
|
6.90007e-05
|
|
|
thrombocytosis, benign familial microcytic
|
[NCBI]
|
6.90007e-05
|
|
|
3-@methylcrotonyl-coa carboxylase 2 deficiency
|
[NCBI]
|
6.90007e-05
|
|
|
pyogenic sterile arthritis, pyoderma gangrenosum, and acne
|
[NCBI]
|
6.90007e-05
|
|
|
LAG5
|
[NCBI]
|
6.64589e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
6.63116e-05
|
|
|
CHAT
|
[NCBI]
|
6.54244e-05
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
6.39415e-05
|
|
|
IDUA
|
[NCBI]
|
6.08841e-05
|
|
|
IFNB1
|
[NCBI]
|
6.06915e-05
|
|
|
PEPD
|
[NCBI]
|
6.06915e-05
|
|
|
GRTH
|
[NCBI]
|
5.97532e-05
|
|
|
myocardial infarction, susceptibility to, 2
|
[NCBI]
|
5.97532e-05
|
|
|
hyperoxaluria, primary, type ii
|
[NCBI]
|
5.97532e-05
|
|
|
complement component 5 deficiency
|
[NCBI]
|
5.97532e-05
|
|
|
dna, satellite, alpha type
|
[NCBI]
|
5.97532e-05
|
|
|
aplastic anemia
|
[NCBI]
|
5.97532e-05
|
|
|
leigh syndrome, x-linked
|
[NCBI]
|
5.97532e-05
|
|
|
fucosidosis
|
[NCBI]
|
5.9692e-05
|
|
|
glycogen storage disease iv
|
[NCBI]
|
5.80297e-05
|
|
|
LSP1
|
[NCBI]
|
5.79026e-05
|
|
|
LILRA3
|
[NCBI]
|
5.79026e-05
|
|
|
SIGLEC10
|
[NCBI]
|
5.79026e-05
|
|
|
immunoglobulin-like transcript 11
|
[NCBI]
|
5.79026e-05
|
|
|
HCK
|
[NCBI]
|
5.79026e-05
|
|
|
TLR4
|
[NCBI]
|
5.7645e-05
|
|
|
AOAH
|
[NCBI]
|
5.73398e-05
|
|
|
GPI
|
[NCBI]
|
5.70015e-05
|
|
|
GLB1
|
[NCBI]
|
5.69055e-05
|
|
|
PRL
|
[NCBI]
|
5.57185e-05
|
|
|
PD
|
[NCBI]
|
5.47761e-05
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
5.42301e-05
|
|
|
CJD
|
[NCBI]
|
5.41938e-05
|
|
|
SELE
|
[NCBI]
|
5.39587e-05
|
|
|
indifference to pain, congenital, autosomal recessive
|
[NCBI]
|
5.29742e-05
|
|
|
asthma, nasal polyps, and aspirin intolerance
|
[NCBI]
|
5.29742e-05
|
|
|
gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
[NCBI]
|
5.29742e-05
|
|
|
spondyloperipheral dysplasia
|
[NCBI]
|
5.29742e-05
|
|
|
HDL1
|
[NCBI]
|
5.29742e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
5.22168e-05
|
|
|
IFNG
|
[NCBI]
|
5.21028e-05
|
|
|
LILRB3
|
[NCBI]
|
5.17373e-05
|
|
|
NPPA
|
[NCBI]
|
5.12372e-05
|
|
|
MBP
|
[NCBI]
|
5.08183e-05
|
|
|
PGM3
|
[NCBI]
|
4.97586e-05
|
|
|
NF2
|
[NCBI]
|
4.87743e-05
|
|
|
complement factor i deficiency
|
[NCBI]
|
4.76491e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
4.76491e-05
|
|
|
fragile site 2q11
|
[NCBI]
|
4.76491e-05
|
|
|
SPG6
|
[NCBI]
|
4.76491e-05
|
|
|
gout, hprt-related
|
[NCBI]
|
4.76491e-05
|
|
|
lactic acidosis, fatal infantile
|
[NCBI]
|
4.76491e-05
|
|
|
LILRB2
|
[NCBI]
|
4.75206e-05
|
|
|
JAM3
|
[NCBI]
|
4.75206e-05
|
|
|
PGK1
|
[NCBI]
|
4.74573e-05
|
|
|
RNASE3
|
[NCBI]
|
4.61926e-05
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
4.56222e-05
|
|
|
HGF
|
[NCBI]
|
4.47437e-05
|
|
|
ALOX12
|
[NCBI]
|
4.43009e-05
|
|
|
HBB
|
[NCBI]
|
4.41746e-05
|
|
|
meningioma, familial
|
[NCBI]
|
4.41429e-05
|
|
|
hemophilia a
|
[NCBI]
|
4.35519e-05
|
|
|
methylmalonic aciduria, cbla type
|
[NCBI]
|
4.32847e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
4.32847e-05
|
|
|
LGMD1A
|
[NCBI]
|
4.32847e-05
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
4.27227e-05
|
|
|
ARSB
|
[NCBI]
|
4.24533e-05
|
|
|
GUSB
|
[NCBI]
|
4.21418e-05
|
|
|
HPRT1
|
[NCBI]
|
4.18086e-05
|
|
|
IRDN
|
[NCBI]
|
4.1695e-05
|
|
|
PTAFR
|
[NCBI]
|
4.1695e-05
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
3.96031e-05
|
|
|
hermaphroditism, true
|
[NCBI]
|
3.96031e-05
|
|
|
TRS
|
[NCBI]
|
3.96031e-05
|
|
|
ITPA
|
[NCBI]
|
3.95068e-05
|
|
|
ACP2
|
[NCBI]
|
3.95068e-05
|
|
|
TNFRSF18
|
[NCBI]
|
3.95068e-05
|
|
|
ADA
|
[NCBI]
|
3.90802e-05
|
|
|
MTND4
|
[NCBI]
|
3.85311e-05
|
|
|
CRH
|
[NCBI]
|
3.80538e-05
|
|
|
PEPC
|
[NCBI]
|
3.7622e-05
|
|
|
PTK2
|
[NCBI]
|
3.72246e-05
|
|
|
TPI1
|
[NCBI]
|
3.65171e-05
|
|
|
SCN3
|
[NCBI]
|
3.64321e-05
|
|
|
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency
|
[NCBI]
|
3.64321e-05
|
|
|
pheochromocytoma
|
[NCBI]
|
3.64321e-05
|
|
|
homocysteinemia
|
[NCBI]
|
3.64321e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 2a
|
[NCBI]
|
3.64321e-05
|
|
|
CMT2A2
|
[NCBI]
|
3.64321e-05
|
|
|
LILRB5
|
[NCBI]
|
3.57997e-05
|
|
|
NLRP6
|
[NCBI]
|
3.57997e-05
|
|
|
x123 gene
|
[NCBI]
|
3.57997e-05
|
|
|
TFB2M
|
[NCBI]
|
3.57997e-05
|
|
|
MYO1B
|
[NCBI]
|
3.57997e-05
|
|
|
C17ORF38
|
[NCBI]
|
3.57997e-05
|
|
|
AMICA1
|
[NCBI]
|
3.57997e-05
|
|
|
killer-specific secretory protein, 37-kd
|
[NCBI]
|
3.57997e-05
|
|
|
hemoglobin--alpha locus 3
|
[NCBI]
|
3.57997e-05
|
|
|
LEUT
|
[NCBI]
|
3.57997e-05
|
|
|
EMR3
|
[NCBI]
|
3.57997e-05
|
|
|
NARS
|
[NCBI]
|
3.57997e-05
|
|
|
SECTM1
|
[NCBI]
|
3.57997e-05
|
|
|
neutrophil-specific antigen: nd1
|
[NCBI]
|
3.57997e-05
|
|
|
thrombocytosis, familial x-linked
|
[NCBI]
|
3.57997e-05
|
|
|
KIAA1949
|
[NCBI]
|
3.57997e-05
|
|
|
RIN2
|
[NCBI]
|
3.57997e-05
|
|
|
SLC2A6
|
[NCBI]
|
3.57997e-05
|
|
|
SLC2A9
|
[NCBI]
|
3.57997e-05
|
|
|
LILRA1
|
[NCBI]
|
3.57997e-05
|
|
|
CLEC2B
|
[NCBI]
|
3.57997e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
3.46648e-05
|
|
|
SPN
|
[NCBI]
|
3.44945e-05
|
|
|
LYZ
|
[NCBI]
|
3.44945e-05
|
|
|
LTK
|
[NCBI]
|
3.44945e-05
|
|
|
KIR3DL1
|
[NCBI]
|
3.44945e-05
|
|
|
SCIDX1
|
[NCBI]
|
3.41663e-05
|
|
|
SCA10
|
[NCBI]
|
3.36574e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
3.36574e-05
|
|
|
hematopoietic stem cell kinetics, control of
|
[NCBI]
|
3.36574e-05
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
3.36574e-05
|
|
|
CX3CL1
|
[NCBI]
|
3.31676e-05
|
|
|
CFI
|
[NCBI]
|
3.31676e-05
|
|
|
IDH1
|
[NCBI]
|
3.19612e-05
|
|
|
ME2
|
[NCBI]
|
3.19612e-05
|
|
|
NAGA
|
[NCBI]
|
3.19612e-05
|
|
|
PGD
|
[NCBI]
|
3.19612e-05
|
|
|
AS
|
[NCBI]
|
3.16293e-05
|
|
|
AFP
|
[NCBI]
|
3.15419e-05
|
|
|
wagr syndrome
|
[NCBI]
|
3.11993e-05
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
3.11993e-05
|
|
|
CYBA
|
[NCBI]
|
3.08559e-05
|
|
|
AR
|
[NCBI]
|
3.06794e-05
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
3.05325e-05
|
|
|
SELP
|
[NCBI]
|
2.98366e-05
|
|
|
CYP2D6
|
[NCBI]
|
2.98366e-05
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
2.98366e-05
|
|
|
LPL
|
[NCBI]
|
2.96609e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
2.92539e-05
|
|
|
metachromatic leukodystrophy due to saposin b deficiency
|
[NCBI]
|
2.89999e-05
|
|
|
aging
|
[NCBI]
|
2.89999e-05
|
|
|
DMC
|
[NCBI]
|
2.89999e-05
|
|
|
CMT2A1
|
[NCBI]
|
2.89999e-05
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
2.89999e-05
|
|
|
polycythemia vera
|
[NCBI]
|
2.89999e-05
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
2.89999e-05
|
|
|
GSR
|
[NCBI]
|
2.88489e-05
|
|
|
CFTR
|
[NCBI]
|
2.81619e-05
|
|
|
PCCB
|
[NCBI]
|
2.80106e-05
|
|
|
DEFA1
|
[NCBI]
|
2.71864e-05
|
|
|
FRA16A
|
[NCBI]
|
2.7016e-05
|
|
|
propionic acidemia
|
[NCBI]
|
2.7016e-05
|
|
|
NM
|
[NCBI]
|
2.7016e-05
|
|
|
biotinidase deficiency
|
[NCBI]
|
2.7016e-05
|
|
|
mucopolysaccharidosis type iiic
|
[NCBI]
|
2.7016e-05
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
2.7016e-05
|
|
|
COL2A1
|
[NCBI]
|
2.65264e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
2.63954e-05
|
|
|
von willebrand disease
|
[NCBI]
|
2.61687e-05
|
|
|
PLEK
|
[NCBI]
|
2.58661e-05
|
|
|
KIR2DS5
|
[NCBI]
|
2.58661e-05
|
|
|
TPK1
|
[NCBI]
|
2.58661e-05
|
|
|
S5
|
[NCBI]
|
2.58661e-05
|
|
|
NPL
|
[NCBI]
|
2.58661e-05
|
|
|
ARHGAP4
|
[NCBI]
|
2.58661e-05
|
|
|
SIGLEC9
|
[NCBI]
|
2.58661e-05
|
|
|
TCF9
|
[NCBI]
|
2.58661e-05
|
|
|
LENG5
|
[NCBI]
|
2.58661e-05
|
|
|
EPHB6
|
[NCBI]
|
2.58661e-05
|
|
|
LENG4
|
[NCBI]
|
2.58661e-05
|
|
|
IL4I1
|
[NCBI]
|
2.58661e-05
|
|
|
CD300C
|
[NCBI]
|
2.58661e-05
|
|
|
MYO7B
|
[NCBI]
|
2.58661e-05
|
|
|
r binder protein
|
[NCBI]
|
2.58661e-05
|
|
|
LTB4DH
|
[NCBI]
|
2.58661e-05
|
|
|
VPS45A
|
[NCBI]
|
2.58661e-05
|
|
|
STK10
|
[NCBI]
|
2.58661e-05
|
|
|
KIR2DS1
|
[NCBI]
|
2.58661e-05
|
|
|
ADAM8
|
[NCBI]
|
2.58661e-05
|
|
|
PLS3
|
[NCBI]
|
2.58661e-05
|
|
|
SEC14L1
|
[NCBI]
|
2.58661e-05
|
|
|
CENTD3
|
[NCBI]
|
2.58661e-05
|
|
|
LOXL3
|
[NCBI]
|
2.58661e-05
|
|
|
AP2S1
|
[NCBI]
|
2.58661e-05
|
|
|
SP140
|
[NCBI]
|
2.58661e-05
|
|
|
ALOX15B
|
[NCBI]
|
2.58661e-05
|
|
|
LDHA
|
[NCBI]
|
2.56829e-05
|
|
|
CRC
|
[NCBI]
|
2.54212e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
2.52143e-05
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
2.52143e-05
|
|
|
PI3
|
[NCBI]
|
2.49935e-05
|
|
|
SHH
|
[NCBI]
|
2.48893e-05
|
|
|
LCN2
|
[NCBI]
|
2.38618e-05
|
|
|
FCAS
|
[NCBI]
|
2.35687e-05
|
|
|
SCN1
|
[NCBI]
|
2.35687e-05
|
|
|
NAT1
|
[NCBI]
|
2.31292e-05
|
|
|
ETS1
|
[NCBI]
|
2.31292e-05
|
|
|
HK1
|
[NCBI]
|
2.31292e-05
|
|
|
CYP17A1
|
[NCBI]
|
2.31292e-05
|
|
|
GLA
|
[NCBI]
|
2.25659e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.21881e-05
|
|
|
SYTL1
|
[NCBI]
|
2.21479e-05
|
|
|
SLC46A2
|
[NCBI]
|
2.21479e-05
|
|
|
KIR2DS4
|
[NCBI]
|
2.21479e-05
|
|
|
PA2G4
|
[NCBI]
|
2.21479e-05
|
|
|
MZF1
|
[NCBI]
|
2.21479e-05
|
|
|
ALOX15
|
[NCBI]
|
2.21479e-05
|
|
|
MYO1F
|
[NCBI]
|
2.21479e-05
|
|
|
HCLS1
|
[NCBI]
|
2.21479e-05
|
|
|
leukocyte-derived arginine aminopeptidase
|
[NCBI]
|
2.21479e-05
|
|
|
MANBA
|
[NCBI]
|
2.21479e-05
|
|
|
IL1F5
|
[NCBI]
|
2.21479e-05
|
|
|
NIPA1
|
[NCBI]
|
2.21479e-05
|
|
|
EPR1
|
[NCBI]
|
2.21479e-05
|
|
|
GRAP2
|
[NCBI]
|
2.21479e-05
|
|
|
KIR3DL3
|
[NCBI]
|
2.21479e-05
|
|
|
CCRL1
|
[NCBI]
|
2.21479e-05
|
|
|
PON3
|
[NCBI]
|
2.21479e-05
|
|
|
DNASE1L2
|
[NCBI]
|
2.21479e-05
|
|
|
ITGB8
|
[NCBI]
|
2.21479e-05
|
|
|
PTPN7
|
[NCBI]
|
2.21479e-05
|
|
|
MEP1B
|
[NCBI]
|
2.21479e-05
|
|
|
LGALS9
|
[NCBI]
|
2.21479e-05
|
|
|
HYAL3
|
[NCBI]
|
2.21479e-05
|
|
|
NLRP12
|
[NCBI]
|
2.21479e-05
|
|
|
LARS
|
[NCBI]
|
2.21479e-05
|
|
|
SGD
|
[NCBI]
|
2.20584e-05
|
|
|
CYBB
|
[NCBI]
|
2.10188e-05
|
|
|
TERC
|
[NCBI]
|
2.10188e-05
|
|
|
CVID
|
[NCBI]
|
2.08992e-05
|
|
|
CCL2
|
[NCBI]
|
2.08025e-05
|
|
|
pfeiffer syndrome
|
[NCBI]
|
2.06663e-05
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
2.06663e-05
|
|
|
CYSLTR2
|
[NCBI]
|
1.97509e-05
|
|
|
ALDH4A1
|
[NCBI]
|
1.97509e-05
|
|
|
FCN1
|
[NCBI]
|
1.97509e-05
|
|
|
DOCK2
|
[NCBI]
|
1.97509e-05
|
|
|
CCL15
|
[NCBI]
|
1.97509e-05
|
|
|
RPS9
|
[NCBI]
|
1.97509e-05
|
|
|
CXCL16
|
[NCBI]
|
1.97509e-05
|
|
|
HYAL1
|
[NCBI]
|
1.97509e-05
|
|
|
PDCD1LG2
|
[NCBI]
|
1.97509e-05
|
|
|
ATXN10
|
[NCBI]
|
1.97509e-05
|
|
|
DGKA
|
[NCBI]
|
1.97509e-05
|
|
|
GABRB1
|
[NCBI]
|
1.97509e-05
|
|
|
APCS
|
[NCBI]
|
1.96509e-05
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
1.93786e-05
|
|
|
glutaric acidemia i
|
[NCBI]
|
1.93786e-05
|
|
|
GALT
|
[NCBI]
|
1.88211e-05
|
|
|
IL8
|
[NCBI]
|
1.88211e-05
|
|
|
GAA
|
[NCBI]
|
1.88211e-05
|
|
|
GDXY
|
[NCBI]
|
1.84278e-05
|
|
|
CES
|
[NCBI]
|
1.82967e-05
|
|
|
CLN1
|
[NCBI]
|
1.81837e-05
|
|
|
SPG4
|
[NCBI]
|
1.81837e-05
|
|
|
CS
|
[NCBI]
|
1.79814e-05
|
|
|
KIR2DL3
|
[NCBI]
|
1.79814e-05
|
|
|
MYO10
|
[NCBI]
|
1.79814e-05
|
|
|
LILRA2
|
[NCBI]
|
1.79814e-05
|
|
|
PLA2G1B
|
[NCBI]
|
1.79814e-05
|
|
|
SLC35C1
|
[NCBI]
|
1.79814e-05
|
|
|
MSMB
|
[NCBI]
|
1.79814e-05
|
|
|
LILRB4
|
[NCBI]
|
1.79814e-05
|
|
|
HK3
|
[NCBI]
|
1.79814e-05
|
|
|
PRKAR1B
|
[NCBI]
|
1.79814e-05
|
|
|
ATP1A4
|
[NCBI]
|
1.79814e-05
|
|
|
ASGR1
|
[NCBI]
|
1.79814e-05
|
|
|
MMP25
|
[NCBI]
|
1.79814e-05
|
|
|
BLVRA
|
[NCBI]
|
1.79814e-05
|
|
|
LGALS2
|
[NCBI]
|
1.79814e-05
|
|
|
DDX11
|
[NCBI]
|
1.79814e-05
|
|
|
TJP2
|
[NCBI]
|
1.79814e-05
|
|
|
MCCC2
|
[NCBI]
|
1.79814e-05
|
|
|
KIR3DL2
|
[NCBI]
|
1.79814e-05
|
|
|
HCF2
|
[NCBI]
|
1.79814e-05
|
|
|
FUT7
|
[NCBI]
|
1.79814e-05
|
|
|
IFNGR2
|
[NCBI]
|
1.79814e-05
|
|
|
COTL1
|
[NCBI]
|
1.79814e-05
|
|
|
HMGN1
|
[NCBI]
|
1.79814e-05
|
|
|
PIK3CD
|
[NCBI]
|
1.79814e-05
|
|
|
TG
|
[NCBI]
|
1.76368e-05
|
|
|
INS
|
[NCBI]
|
1.74828e-05
|
|
|
SCA1
|
[NCBI]
|
1.71669e-05
|
|
|
HAE
|
[NCBI]
|
1.70718e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
1.70718e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
1.70718e-05
|
|
|
PDHA1
|
[NCBI]
|
1.69798e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
1.68719e-05
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
1.66457e-05
|
|
|
DPYS
|
[NCBI]
|
1.65814e-05
|
|
|
MDH2
|
[NCBI]
|
1.65814e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
1.65814e-05
|
|
|
ITGAM
|
[NCBI]
|
1.65814e-05
|
|
|
FER
|
[NCBI]
|
1.65814e-05
|
|
|
KTN1
|
[NCBI]
|
1.65814e-05
|
|
|
P2RY6
|
[NCBI]
|
1.65814e-05
|
|
|
ribonucleic acid, ribosomal, 5s
|
[NCBI]
|
1.65814e-05
|
|
|
GRHPR
|
[NCBI]
|
1.65814e-05
|
|
|
minor histocompatibility antigen ha-1
|
[NCBI]
|
1.65814e-05
|
|
|
CYSLTR1
|
[NCBI]
|
1.65814e-05
|
|
|
ADSS
|
[NCBI]
|
1.65814e-05
|
|
|
GZMK
|
[NCBI]
|
1.65814e-05
|
|
|
FCAR
|
[NCBI]
|
1.65814e-05
|
|
|
P2RX1
|
[NCBI]
|
1.65814e-05
|
|
|
NPPB
|
[NCBI]
|
1.65814e-05
|
|
|
SELPLG
|
[NCBI]
|
1.65814e-05
|
|
|
PCNA
|
[NCBI]
|
1.63129e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
1.60345e-05
|
|
|
thrombocythemia, essential
|
[NCBI]
|
1.60345e-05
|
|
|
TLR5
|
[NCBI]
|
1.60069e-05
|
|
|
BL
|
[NCBI]
|
1.5963e-05
|
|
|
ADCYAP1
|
[NCBI]
|
1.59133e-05
|
|
|
GH1
|
[NCBI]
|
1.57013e-05
|
|
|
SCARF1
|
[NCBI]
|
1.54256e-05
|
|
|
PI6
|
[NCBI]
|
1.54256e-05
|
|
|
CTNS
|
[NCBI]
|
1.54256e-05
|
|
|
CTCFL
|
[NCBI]
|
1.54256e-05
|
|
|
IL21
|
[NCBI]
|
1.54256e-05
|
|
|
ATP2B1
|
[NCBI]
|
1.54256e-05
|
|
|
LCP2
|
[NCBI]
|
1.54256e-05
|
|
|
MMRN1
|
[NCBI]
|
1.54256e-05
|
|
|
glycogen storage disease vi
|
[NCBI]
|
1.54256e-05
|
|
|
PHKB
|
[NCBI]
|
1.54256e-05
|
|
|
KIR2DL4
|
[NCBI]
|
1.54256e-05
|
|
|
PBEF1
|
[NCBI]
|
1.54256e-05
|
|
|
GLUD2
|
[NCBI]
|
1.54256e-05
|
|
|
PSTPIP1
|
[NCBI]
|
1.54256e-05
|
|
|
PON2
|
[NCBI]
|
1.54256e-05
|
|
|
GNAT2
|
[NCBI]
|
1.54256e-05
|
|
|
PPL
|
[NCBI]
|
1.54256e-05
|
|
|
LILRB1
|
[NCBI]
|
1.54256e-05
|
|
|
MAS
|
[NCBI]
|
1.50864e-05
|
|
|
FRDA
|
[NCBI]
|
1.50864e-05
|
|
|
CML
|
[NCBI]
|
1.50648e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
1.50648e-05
|
|
|
APOA2
|
[NCBI]
|
1.44434e-05
|
|
|
RGN
|
[NCBI]
|
1.44434e-05
|
|
|
LECT2
|
[NCBI]
|
1.44434e-05
|
|
|
CYP27A1
|
[NCBI]
|
1.44434e-05
|
|
|
IL21R
|
[NCBI]
|
1.44434e-05
|
|
|
methemoglobinemia due to deficiency of cytochrome b5
|
[NCBI]
|
1.44434e-05
|
|
|
COL4A6
|
[NCBI]
|
1.44434e-05
|
|
|
PGAM1
|
[NCBI]
|
1.44434e-05
|
|
|
CD38
|
[NCBI]
|
1.44434e-05
|
|
|
PITPN
|
[NCBI]
|
1.44434e-05
|
|
|
PECAM1
|
[NCBI]
|
1.44434e-05
|
|
|
IGHV
|
[NCBI]
|
1.44434e-05
|
|
|
CD74
|
[NCBI]
|
1.44434e-05
|
|
|
KEL
|
[NCBI]
|
1.44434e-05
|
|
|
RNASE2
|
[NCBI]
|
1.44124e-05
|
|
|
MMP9
|
[NCBI]
|
1.4294e-05
|
|
|
CNC1
|
[NCBI]
|
1.41564e-05
|
|
|
CCL21
|
[NCBI]
|
1.37811e-05
|
|
|
CD47
|
[NCBI]
|
1.37811e-05
|
|
|
CCR6
|
[NCBI]
|
1.35909e-05
|
|
|
CLEC7A
|
[NCBI]
|
1.35909e-05
|
|
|
SLC5A6
|
[NCBI]
|
1.35909e-05
|
|
|
CCR7
|
[NCBI]
|
1.35909e-05
|
|
|
CAPN10
|
[NCBI]
|
1.35909e-05
|
|
|
ITGA5
|
[NCBI]
|
1.35909e-05
|
|
|
LTA4H
|
[NCBI]
|
1.35909e-05
|
|
|
DNASE2
|
[NCBI]
|
1.35909e-05
|
|
|
ATP1A1
|
[NCBI]
|
1.35909e-05
|
|
|
C1NH
|
[NCBI]
|
1.35909e-05
|
|
|
MTTI
|
[NCBI]
|
1.35909e-05
|
|
|
ITGA4
|
[NCBI]
|
1.35909e-05
|
|
|
LTB4R
|
[NCBI]
|
1.35909e-05
|
|
|
PDXK
|
[NCBI]
|
1.35909e-05
|
|
|
CXCL11
|
[NCBI]
|
1.35909e-05
|
|
|
TSHR
|
[NCBI]
|
1.35341e-05
|
|
|
KLK3
|
[NCBI]
|
1.34911e-05
|
|
|
TLR9
|
[NCBI]
|
1.33488e-05
|
|
|
MADD
|
[NCBI]
|
1.33041e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.29212e-05
|
|
|
TNFSF18
|
[NCBI]
|
1.28392e-05
|
|
|
LAMC1
|
[NCBI]
|
1.28392e-05
|
|
|
MCOLN1
|
[NCBI]
|
1.28392e-05
|
|
|
F2
|
[NCBI]
|
1.28392e-05
|
|
|
SFTPC
|
[NCBI]
|
1.28392e-05
|
|
|
COL4A4
|
[NCBI]
|
1.28392e-05
|
|
|
NLRP3
|
[NCBI]
|
1.28392e-05
|
|
|
PDCD1LG1
|
[NCBI]
|
1.28392e-05
|
|
|
APRT
|
[NCBI]
|
1.27146e-05
|
|
|
NP
|
[NCBI]
|
1.2604e-05
|
|
|
SGBS1
|
[NCBI]
|
1.25032e-05
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
1.25032e-05
|
|
|
SUZ12
|
[NCBI]
|
1.21679e-05
|
|
|
ATRN
|
[NCBI]
|
1.21679e-05
|
|
|
COL6A2
|
[NCBI]
|
1.21679e-05
|
|
|
SELL
|
[NCBI]
|
1.21679e-05
|
|
|
CD151
|
[NCBI]
|
1.21679e-05
|
|
|
ACO2
|
[NCBI]
|
1.21679e-05
|
|
|
CX3CR1
|
[NCBI]
|
1.21679e-05
|
|
|
B4GALT1
|
[NCBI]
|
1.21679e-05
|
|
|
farber lipogranulomatosis
|
[NCBI]
|
1.21679e-05
|
|
|
diphosphoglycerate mutase deficiency of erythrocyte
|
[NCBI]
|
1.21679e-05
|
|
|
KIR2DL1
|
[NCBI]
|
1.21679e-05
|
|
|
TF
|
[NCBI]
|
1.19102e-05
|
|
|
central core disease of muscle
|
[NCBI]
|
1.17496e-05
|
|
|
ALOX5AP
|
[NCBI]
|
1.15624e-05
|
|
|
BCL2L11
|
[NCBI]
|
1.15624e-05
|
|
|
CPT1A
|
[NCBI]
|
1.15624e-05
|
|
|
MPI
|
[NCBI]
|
1.15624e-05
|
|
|
CD14
|
[NCBI]
|
1.15624e-05
|
|
|
INDO
|
[NCBI]
|
1.15624e-05
|
|
|
ALOX5
|
[NCBI]
|
1.15624e-05
|
|
|
ADSL
|
[NCBI]
|
1.15624e-05
|
|
|
PTS
|
[NCBI]
|
1.15624e-05
|
|
|
MEFV
|
[NCBI]
|
1.15624e-05
|
|
|
RUNX3
|
[NCBI]
|
1.15624e-05
|
|
|
ODC1
|
[NCBI]
|
1.15624e-05
|
|
|
HDAC5
|
[NCBI]
|
1.15624e-05
|
|
|
RPS14
|
[NCBI]
|
1.15624e-05
|
|
|
LBR
|
[NCBI]
|
1.15559e-05
|
|
|
TYR
|
[NCBI]
|
1.13597e-05
|
|
|
DPYD
|
[NCBI]
|
1.10117e-05
|
|
|
AGTR2
|
[NCBI]
|
1.10117e-05
|
|
|
MNDA
|
[NCBI]
|
1.10117e-05
|
|
|
FABP2
|
[NCBI]
|
1.10117e-05
|
|
|
ACO1
|
[NCBI]
|
1.10117e-05
|
|
|
CBP
|
[NCBI]
|
1.10117e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.07955e-05
|
|
|
phenylketonuria
|
[NCBI]
|
1.07955e-05
|
|
|
TFPI
|
[NCBI]
|
1.05212e-05
|
|
|
SAA1
|
[NCBI]
|
1.05073e-05
|
|
|
AQP9
|
[NCBI]
|
1.05073e-05
|
|
|
PIK3CG
|
[NCBI]
|
1.05073e-05
|
|
|
SLC12A3
|
[NCBI]
|
1.05073e-05
|
|
|
SRA2
|
[NCBI]
|
1.05073e-05
|
|
|
MDD
|
[NCBI]
|
1.02313e-05
|
|
|
PFKM
|
[NCBI]
|
1.00425e-05
|
|
|
CR1
|
[NCBI]
|
1.00425e-05
|
|
|
G6PT1
|
[NCBI]
|
1.00425e-05
|
|
|
TLR1
|
[NCBI]
|
1.00425e-05
|
|
|
CLDN1
|
[NCBI]
|
1.00425e-05
|
|
|
PFKL
|
[NCBI]
|
1.00425e-05
|
|
|
RHD
|
[NCBI]
|
1.00425e-05
|
|
|
CYP1A1
|
[NCBI]
|
9.78902e-06
|
|
|
PLAT
|
[NCBI]
|
9.61218e-06
|
|
|
IRF7
|
[NCBI]
|
9.61218e-06
|
|
|
CCL19
|
[NCBI]
|
9.61218e-06
|
|
|
GALK1
|
[NCBI]
|
9.61218e-06
|
|
|
TNXB
|
[NCBI]
|
9.61218e-06
|
|
|
DDR1
|
[NCBI]
|
9.61218e-06
|
|
|
APOC2
|
[NCBI]
|
9.61218e-06
|
|
|
HMOX1
|
[NCBI]
|
9.61218e-06
|
|
|
MJD
|
[NCBI]
|
9.58907e-06
|
|
|
CD1D
|
[NCBI]
|
9.21189e-06
|
|
|
GSTM1
|
[NCBI]
|
9.21189e-06
|
|
|
XCL1
|
[NCBI]
|
9.21189e-06
|
|
|
TLR2
|
[NCBI]
|
9.18634e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
9.16573e-06
|
|
|
MCP
|
[NCBI]
|
8.86532e-06
|
|
|
CCND1
|
[NCBI]
|
8.84801e-06
|
|
|
OPA1
|
[NCBI]
|
8.83813e-06
|
|
|
HBA2
|
[NCBI]
|
8.83813e-06
|
|
|
MIF
|
[NCBI]
|
8.83813e-06
|
|
|
AHC
|
[NCBI]
|
8.57615e-06
|
|
|
APOB
|
[NCBI]
|
8.56366e-06
|
|
|
NEB
|
[NCBI]
|
8.48794e-06
|
|
|
MAN2B1
|
[NCBI]
|
8.48794e-06
|
|
|
CCR2
|
[NCBI]
|
8.48794e-06
|
|
|
MTCO2
|
[NCBI]
|
8.48794e-06
|
|
|
F2RL1
|
[NCBI]
|
8.48794e-06
|
|
|
SN
|
[NCBI]
|
8.48794e-06
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
8.48794e-06
|
|
|
CASP8
|
[NCBI]
|
8.48794e-06
|
|
|
isoniazid inactivation
|
[NCBI]
|
8.48794e-06
|
|
|
IL3
|
[NCBI]
|
8.42586e-06
|
|
|
XK
|
[NCBI]
|
8.15884e-06
|
|
|
CXCL13
|
[NCBI]
|
8.15884e-06
|
|
|
LCP1
|
[NCBI]
|
8.15884e-06
|
|
|
SLC25A20
|
[NCBI]
|
8.15884e-06
|
|
|
glioma of brain, familial
|
[NCBI]
|
8.04205e-06
|
|
|
RB1
|
[NCBI]
|
7.87222e-06
|
|
|
CSF1
|
[NCBI]
|
7.84872e-06
|
|
|
RHCE
|
[NCBI]
|
7.84872e-06
|
|
|
C3
|
[NCBI]
|
7.84872e-06
|
|
|
FMR1
|
[NCBI]
|
7.70314e-06
|
|
|
LDLR
|
[NCBI]
|
7.61985e-06
|
|
|
VDR
|
[NCBI]
|
7.57228e-06
|
|
|
EDN3
|
[NCBI]
|
7.55577e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
7.55577e-06
|
|
|
CCL25
|
[NCBI]
|
7.55577e-06
|
|
|
BMD
|
[NCBI]
|
7.53654e-06
|
|
|
LRRK2
|
[NCBI]
|
7.27842e-06
|
|
|
MAP3K7
|
[NCBI]
|
7.27842e-06
|
|
|
GALC
|
[NCBI]
|
7.27842e-06
|
|
|
ITGB1
|
[NCBI]
|
7.27842e-06
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
7.27842e-06
|
|
|
GZMA
|
[NCBI]
|
7.27842e-06
|
|
|
LDHB
|
[NCBI]
|
7.27842e-06
|
|
|
THRA
|
[NCBI]
|
7.27842e-06
|
|
|
ADRB2
|
[NCBI]
|
7.27842e-06
|
|
|
CMH
|
[NCBI]
|
7.19709e-06
|
|
|
PXE
|
[NCBI]
|
7.1447e-06
|
|
|
DCK
|
[NCBI]
|
7.13694e-06
|
|
|
CCL22
|
[NCBI]
|
7.05348e-06
|
|
|
ABCC6
|
[NCBI]
|
7.01532e-06
|
|
|
MFN2
|
[NCBI]
|
7.01532e-06
|
|
|
TBG
|
[NCBI]
|
7.01532e-06
|
|
|
CDA
|
[NCBI]
|
7.01532e-06
|
|
|
MUC1
|
[NCBI]
|
6.8945e-06
|
|
|
PRKAR1A
|
[NCBI]
|
6.76527e-06
|
|
|
MTTK
|
[NCBI]
|
6.76527e-06
|
|
|
GAPDH
|
[NCBI]
|
6.66999e-06
|
|
|
SPP1
|
[NCBI]
|
6.62232e-06
|
|
|
NSF
|
[NCBI]
|
6.61357e-06
|
|
|
XLP1
|
[NCBI]
|
6.60449e-06
|
|
|
FGA
|
[NCBI]
|
6.52724e-06
|
|
|
CD59
|
[NCBI]
|
6.52724e-06
|
|
|
HGFAC
|
[NCBI]
|
6.52724e-06
|
|
|
GK
|
[NCBI]
|
6.52724e-06
|
|
|
GZMB
|
[NCBI]
|
6.52724e-06
|
|
|
POU1F1
|
[NCBI]
|
6.52724e-06
|
|
|
IGHG1
|
[NCBI]
|
6.52724e-06
|
|
|
ELA2
|
[NCBI]
|
6.52724e-06
|
|
|
EPO
|
[NCBI]
|
6.464e-06
|
|
|
HP
|
[NCBI]
|
6.46341e-06
|
|
|
CD44
|
[NCBI]
|
6.3003e-06
|
|
|
glycogen storage disease i
|
[NCBI]
|
6.3003e-06
|
|
|
FY
|
[NCBI]
|
6.3003e-06
|
|
|
galactosemia
|
[NCBI]
|
6.17493e-06
|
|
|
coproporphyria
|
[NCBI]
|
6.08362e-06
|
|
|
TSC1
|
[NCBI]
|
6.08362e-06
|
|
|
JAK2
|
[NCBI]
|
5.9783e-06
|
|
|
VEGF
|
[NCBI]
|
5.91285e-06
|
|
|
IL12B
|
[NCBI]
|
5.87648e-06
|
|
|
CD40LG
|
[NCBI]
|
5.87648e-06
|
|
|
CDSP
|
[NCBI]
|
5.76787e-06
|
|
|
MFS
|
[NCBI]
|
5.75919e-06
|
|
|
BCHE
|
[NCBI]
|
5.71522e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
5.67821e-06
|
|
|
DMD
|
[NCBI]
|
5.59306e-06
|
|
|
REN
|
[NCBI]
|
5.48823e-06
|
|
|
FOLH1
|
[NCBI]
|
5.48823e-06
|
|
|
MAG
|
[NCBI]
|
5.4715e-06
|
|
|
CDH1
|
[NCBI]
|
5.30599e-06
|
|
|
CTSC
|
[NCBI]
|
5.30599e-06
|
|
|
GC
|
[NCBI]
|
5.30599e-06
|
|
|
ALAD
|
[NCBI]
|
5.30599e-06
|
|
|
GPX1
|
[NCBI]
|
5.30599e-06
|
|
|
PPARA
|
[NCBI]
|
5.23907e-06
|
|
|
PGM1
|
[NCBI]
|
5.13102e-06
|
|
|
ABCA1
|
[NCBI]
|
5.13102e-06
|
|
|
PPT1
|
[NCBI]
|
5.13102e-06
|
|
|
CCR5
|
[NCBI]
|
5.13102e-06
|
|
|
ABCC1
|
[NCBI]
|
5.12029e-06
|
|
|
PLAUR
|
[NCBI]
|
5.02292e-06
|
|
|
SNRPN
|
[NCBI]
|
4.96287e-06
|
|
|
GRN
|
[NCBI]
|
4.96287e-06
|
|
|
AHR
|
[NCBI]
|
4.89266e-06
|
|
|
ILK
|
[NCBI]
|
4.86855e-06
|
|
|
MBL2
|
[NCBI]
|
4.86122e-06
|
|
|
ARSA
|
[NCBI]
|
4.80114e-06
|
|
|
SLAMF1
|
[NCBI]
|
4.80114e-06
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
4.76272e-06
|
|
|
temporal arteritis
|
[NCBI]
|
4.6978e-06
|
|
|
CMT1B
|
[NCBI]
|
4.67001e-06
|
|
|
FXN
|
[NCBI]
|
4.64546e-06
|
|
|
RTT
|
[NCBI]
|
4.6317e-06
|
|
|
ABCB1
|
[NCBI]
|
4.5517e-06
|
|
|
NF2
|
[NCBI]
|
4.49551e-06
|
|
|
CXCR4
|
[NCBI]
|
4.49551e-06
|
|
|
OSM
|
[NCBI]
|
4.43564e-06
|
|
|
TNFSF11
|
[NCBI]
|
4.40356e-06
|
|
|
HRAS
|
[NCBI]
|
4.07698e-06
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
4.03069e-06
|
|
|
GJA1
|
[NCBI]
|
3.89476e-06
|
|
|
MYH7
|
[NCBI]
|
3.82148e-06
|
|
|
hypertension, essential
|
[NCBI]
|
3.73615e-06
|
|
|
PROCR
|
[NCBI]
|
3.58274e-06
|
|
|
AGER
|
[NCBI]
|
3.47705e-06
|
|
|
THRB
|
[NCBI]
|
3.46917e-06
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
3.4573e-06
|
|
|
BWS
|
[NCBI]
|
3.44264e-06
|
|
|
GHRH
|
[NCBI]
|
3.37319e-06
|
|
|
NFKB1
|
[NCBI]
|
3.35924e-06
|
|
|
PARK2
|
[NCBI]
|
3.35924e-06
|
|
|
INSL3
|
[NCBI]
|
3.25279e-06
|
|
|
COL1A2
|
[NCBI]
|
3.25279e-06
|
|
|
VHL
|
[NCBI]
|
3.04974e-06
|
|
|
RLBP1
|
[NCBI]
|
3.04974e-06
|
|
|
DFFB
|
[NCBI]
|
3.04974e-06
|
|
|
TNFSF6
|
[NCBI]
|
3.01075e-06
|
|
|
MTTL1
|
[NCBI]
|
2.95288e-06
|
|
|
DCT
|
[NCBI]
|
2.95288e-06
|
|
|
AIS
|
[NCBI]
|
2.911e-06
|
|
|
GCCR
|
[NCBI]
|
2.85896e-06
|
|
|
RCC1
|
[NCBI]
|
2.70806e-06
|
|
|
ED1
|
[NCBI]
|
2.70806e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
2.70806e-06
|
|
|
MMP2
|
[NCBI]
|
2.67948e-06
|
|
|
APOE
|
[NCBI]
|
2.62579e-06
|
|
|
GNAS
|
[NCBI]
|
2.59371e-06
|
|
|
PMCH
|
[NCBI]
|
2.57913e-06
|
|
|
APP
|
[NCBI]
|
2.57141e-06
|
|
|
HPS
|
[NCBI]
|
2.52807e-06
|
|
|
REG3A
|
[NCBI]
|
2.51046e-06
|
|
|
JAK3
|
[NCBI]
|
2.51046e-06
|
|
|
BLM
|
[NCBI]
|
2.48533e-06
|
|
|
HEMB
|
[NCBI]
|
2.42963e-06
|
|
|
TTR
|
[NCBI]
|
2.37064e-06
|
|
|
SDC2
|
[NCBI]
|
2.32021e-06
|
|
|
KSS
|
[NCBI]
|
2.28436e-06
|
|
|
CD
|
[NCBI]
|
2.27517e-06
|
|
|
SOD2
|
[NCBI]
|
2.11533e-06
|
|
|
ALB
|
[NCBI]
|
2.06981e-06
|
|
|
ABCD1
|
[NCBI]
|
2.05901e-06
|
|
|
LOX
|
[NCBI]
|
1.99107e-06
|
|
|
PARP1
|
[NCBI]
|
1.92503e-06
|
|
|
HBA1
|
[NCBI]
|
1.92503e-06
|
|
|
TNFSF10
|
[NCBI]
|
1.89991e-06
|
|
|
SDS
|
[NCBI]
|
1.89054e-06
|
|
|
LNS
|
[NCBI]
|
1.89054e-06
|
|
|
KRT20
|
[NCBI]
|
1.86084e-06
|
|
|
CAT
|
[NCBI]
|
1.85214e-06
|
|
|
ACPP
|
[NCBI]
|
1.82852e-06
|
|
|
TLR3
|
[NCBI]
|
1.79843e-06
|
|
|
MPZ
|
[NCBI]
|
1.79843e-06
|
|
|
TP53
|
[NCBI]
|
1.78384e-06
|
|
|
KITLG
|
[NCBI]
|
1.74796e-06
|
|
|
LBP
|
[NCBI]
|
1.73776e-06
|
|
|
CHH
|
[NCBI]
|
1.71513e-06
|
|
|
MS
|
[NCBI]
|
1.71513e-06
|
|
|
SOCS3
|
[NCBI]
|
1.67876e-06
|
|
|
PENK
|
[NCBI]
|
1.67876e-06
|
|
|
IAPP
|
[NCBI]
|
1.64251e-06
|
|
|
DRPLA
|
[NCBI]
|
1.63942e-06
|
|
|
PDCD8
|
[NCBI]
|
1.59703e-06
|
|
|
SLS
|
[NCBI]
|
1.55042e-06
|
|
|
AHO
|
[NCBI]
|
1.55042e-06
|
|
|
TYMS
|
[NCBI]
|
1.53622e-06
|
|
|
DHFR
|
[NCBI]
|
1.49359e-06
|
|
|
COMT
|
[NCBI]
|
1.45135e-06
|
|
|
ZS
|
[NCBI]
|
1.40986e-06
|
|
|
THPO
|
[NCBI]
|
1.40729e-06
|
|
|
TPO
|
[NCBI]
|
1.3169e-06
|
|
|
CLU
|
[NCBI]
|
1.30886e-06
|
|
|
STAT6
|
[NCBI]
|
1.30886e-06
|
|
|
MVP
|
[NCBI]
|
1.26166e-06
|
|
|
ACP5
|
[NCBI]
|
1.23966e-06
|
|
|
ZFP36
|
[NCBI]
|
1.21576e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
1.21576e-06
|
|
|
LPO
|
[NCBI]
|
1.04448e-06
|
|
|
SRY
|
[NCBI]
|
1.04448e-06
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
9.90756e-07
|
|
|
wilson disease
|
[NCBI]
|
9.90756e-07
|
|
|
IL2
|
[NCBI]
|
9.76611e-07
|
|
|
apc gene
|
[NCBI]
|
9.65805e-07
|
|
|
BCR
|
[NCBI]
|
7.97368e-07
|
|
|
HMBS
|
[NCBI]
|
7.54997e-07
|
|
|
CP
|
[NCBI]
|
6.20628e-07
|
|
|
SOD1
|
[NCBI]
|
5.85021e-07
|
|
|
ACE
|
[NCBI]
|
5.23212e-07
|
|
|
COMP
|
[NCBI]
|
5.23212e-07
|
|
|
RA
|
[NCBI]
|
4.36391e-07
|
|
|
FGFR2
|
[NCBI]
|
4.31014e-07
|
|
|
PEDF
|
[NCBI]
|
4.21689e-07
|
|
|
PTEN
|
[NCBI]
|
4.09129e-07
|
|
|
PF4
|
[NCBI]
|
4.08336e-07
|
|
|
PC
|
[NCBI]
|
3.67486e-07
|
|
|
CTGF
|
[NCBI]
|
3.61924e-07
|
|
|
POMC
|
[NCBI]
|
3.41996e-07
|
|
|
leber optic atrophy
|
[NCBI]
|
3.33308e-07
|
|
|
APC
|
[NCBI]
|
3.01969e-07
|
|
|
PLG
|
[NCBI]
|
2.92324e-07
|
|
|
LCAT
|
[NCBI]
|
2.68894e-07
|
|
|
CEACAM5
|
[NCBI]
|
2.57659e-07
|
|
|
GHR
|
[NCBI]
|
2.35217e-07
|
|
|
NF1
|
[NCBI]
|
1.93323e-07
|
|
|
STAT3
|
[NCBI]
|
1.79748e-07
|
|
|
LS
|
[NCBI]
|
1.76025e-07
|
|
|
HD
|
[NCBI]
|
1.35105e-07
|
|
|
SLE
|
[NCBI]
|
1.24941e-07
|
|
|
ADM
|
[NCBI]
|
1.18327e-07
|
|
|
XDH
|
[NCBI]
|
1.13861e-07
|
|
|
GRP
|
[NCBI]
|
1.1241e-07
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
9.1332e-08
|
|
|
ALD
|
[NCBI]
|
9.04938e-08
|
|
|
menkes disease
|
[NCBI]
|
6.67253e-08
|
|
|
RASA1
|
[NCBI]
|
5.91768e-08
|
|
|
NGFR
|
[NCBI]
|
4.61938e-08
|
|
|
DBA
|
[NCBI]
|
1.03363e-08
|
|
|
DMD
|
[NCBI]
|
9.16049e-09
|
|
|
STAT1
|
[NCBI]
|
6.73549e-09
|
|
|
DNMT1
|
[NCBI]
|
1.72578e-09
|
|
|
HDC
|
[NCBI]
|
5.04986e-12
|
|